The healthtech capital investor.

Empowering innovation that improves lives

Healthtech Innovators

about us

understand, advise & shape

MTIP is a pan-European healthtech growth capital investor based in Basel, Switzerland. We invest in digital health and digitally-connected medical device companies, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.

portfolio

our success stories

MTIP has played — and will continue to play — a vital role in opening doors and creating potential partnerships for Tytocare throughout Europe.
Dedi Gilad
Co-Founder & CEO TytoCare
MTIP’s expertise in digital health and its healthcare industry network are key to our development and expansion into new markets.
Leon Lerman
CEO of Cynerio
We are delighted to partner with MTIP. The new financing has enabled us to rapidly roll out our uniquely effective solution to large patient populations across Europe and to further develop the underlying technology to better address patients’ unmet needs.
Dr. Kai Eberhardt
Co-Founder & CEO Oviva

stories

Trends and insights from our healthtech experts

blog

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog

How to pitch to a healthtech Investor

Blog Pitching

news

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

news

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

news

MTIP invests in Trialbee

New investment in Trialbee

news

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round

news

The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April

news

MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020

news

New MTIP investment in Oviva

New investment in Oviva

press

Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper

press

Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019

news

MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio

news

MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article

news

New MTIP investment in Quanta Dialysis Technologies

New investment in Quanta

news

MTIP’s Healthcare Clinic 2018

Healthcare Clinic 2018

press

Interview with Christoph Kausch in biotechandmoney

interview Bioandtechnology

news

New MTIP investment – Nitinotes Series A Round

New investment in Nitinotes

news

New investment in an Israeli based digital health company TytoCare

New investment in TytoCare

news

MTIP joins United Nations-supported Principles for Responsible Investments

MTIP signs Principles for Responsible Investments

news

MTIP invests in Blueprint Genetics

new investment in Blueprint Genetics

news

Final Closing of MTIP Fund 1

Final closing Fund I

newsletter

stay informed!